66 / 89
66
7.
Wildt M, Wuttge DM, Hesselstrand R, Scheja A.
Assessment of capillary density in systemic
sclerosis with three different capillaroscopic
methods. Clin Exp Rheumatol 2012;30(2 Supl.
71):S50-4.
8.
Walker JG, Fritzler MJ. Update on
autoantibodies on systemic sclerosis. Curr Opin
Rheumatol 2007;19:580-91.
9.
Johnson SR, Feldman BM, Hawker GA.
Classification criteria for systemic sclerosis
subsets. J Rheumatol 2007;34:1855-63.
10.
Walker JG, Pope J, Baron M, Leclercq S, Hudson
M, Taillefer S, et al. The development of
systemic sclerosis classification criteria. Clin
Rheumatol 2007;26:1401-9.
11.
Pavlov-Dolijanovic S, Damjanov NS, Stojanovic
RM, Vujasinovic Stupar NZ, Stanisavljevic DM.
Scleroderma pattern of nailfold capillary
changes as predictive value for the development
of a connective tissue disease: a follow-up study
of 3,029 patients with primary Raynaud's
phenomenon. Rheumatol Int 2012;32:3039-45.
12.
McGill NW, Gow PJ. Nailfold capillaroscopy: a
blinded study of its discriminatory value in
scleroderma, systemic lupus erythematosus,
and rheumatoid arthritis. Aust N Z J Med
1986;16:457-60.
13.
Ingegnoli F, Boracchi P, Gualtierotti R, Biganzoli
EM, Zeni S, Lubatti C, Fantini F. Improving
outcome prediction of systemic sclerosis from
isolated Raynaud's phenomenon: role of